SMISEK JEFFERY A sold 55.9% of their position (8.24K shares) of FINCH THERAPEUTICS GROUP, INC. on the open market
Open‑market sale worth $21.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/29/2024ACC: 0000950170-24-038657
Director
Since Mar 2021
-8.24K
Net shares
Net seller
$21.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.64K
Price / share
$2.57
Trade value
$17.07K
% of position
New position
3/28/2024
6.64K→0.00
Common Stock
Indirect
Shares
−1.60K
Price / share
$2.61
Trade value
$4.18K
% of position
19.7%
3/28/2024
8.11K→6.51K
Total
Net shares
−8.24K
Net value
-$21.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/28/2024 | S · Sale | −6.64K | $2.57 | $17.07K | New position | 6.64K | 0.00 |
| Common Stock Indirect | 3/28/2024 | S · Sale | −1.60K | $2.61 | $4.18K | 19.7% | 8.11K | 6.51K |
| Total | −8.24K | -$21.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.26K
Total
40.26K indirect40.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.26K | Indirect |
| Total | 40.26K | 40.26K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported